References
- World Health OrganizationAntimicrobial Resistance: Global Report on Surveillance 2014GenevaWorld Health Organization2014 Available from: http://www.who.int/drugresistance/documents/surveillancereport/en/Accessed October 25, 2018
- PatelSAkhtarNAntimicrobial peptides (AMPs): the quintessential ‘offense and defense’ molecules are more than antimicrobialsBiomed Pharmacother2017951276128328938518
- ReddyKVYederyRDAranhaCAntimicrobial peptides: premises and promisesInt J Antimicrob Agents200424653654715555874
- PasupuletiMSchmidtchenAMalmstenMAntimicrobial peptides: key components of the innate immune systemCrit Rev Biotechnol201232214317122074402
- EckertRRoad to clinical efficacy: challenges and novel strategies for antimicrobial peptide developmentFuture Microbiol20116663565121707311
- BiLYangLNarsimhanGBhuniaAKYaoYDesigning carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptideJ Control Release2011150215015621115078
- HamASCostMRSassiABDezzuttiCSRohanLCTargeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticlesPharm Res200926350251119002569
- MahlapuuMHåkanssonJRingstadLBjörnCAntimicrobial peptides: an emerging category of therapeutic agentsFront Cell Infect Microbiol2016619428083516
- MatouguiNBogeLGrooACLipid-based nanoformulations for peptide deliveryInt J Pharm20165021–2809726899976
- LangeCFHancockRESamuelJFinlayWHIn vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptideJ Pharm Sci200190101647165711745723
- PiotrowskaUSobczakMOledzkaECurrent state of a dual behaviour of antimicrobial peptides-therapeutic agents and promising delivery vectorsChem Biol Drug Des20179061079109328548370
- HeurtaultBSaulnierPPechBProustJEBenoitJPA novel phase inversion-based process for the preparation of lipid nanocarriersPharm Res200219687588012134960
- HureauxJLagarceFGagnadouxFClavreulABenoitJPUrbanTThe adaptation of lipid nanocapsule formulations for blood administration in animalsInt J Pharm2009379226626919467305
- AntonNMojzisovaHPorcherEBenoitJPSaulnierPReverse micelle-loaded lipid nano-emulsions: new technology for nano-encapsulation of hydrophilic materialsInt J Pharm20103981–220420920674723
- VrignaudSAntonNGayetPBenoitJPSaulnierPReverse micelle-loaded lipid nanocarriers: a novel drug delivery system for the sustained release of doxorubicin hydrochlorideEur J Pharm Biopharm201179119720421345371
- VrignaudSHureauxJWackSBenoitJPSaulnierPDesign, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochlorideInt J Pharm20124361–219420022721853
- VonarbourgAPassiraniCDesigauxLThe encapsulation of DNA molecules within biomimetic lipid nanocapsulesBiomaterials200930183197320419329183
- SchneiderTKruseTWimmerRPlectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid IIScience201032859821168117220508130
- MygindPHFischerRLSchnorrKMPlectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungusNature2005437706197598016222292
- LociuroSNeveSKjærulfSNordkildPAP138, a second generation plectasin, shows good bactericidal properties and long post-antibiotic effectFinal Programme; European Congress of Clinical Microbiology and Infectious Diseases425–28\2015Copenhagen, Denmark
- StryjewskiMEChambersHFSkin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureusClin Infect Dis200846Suppl 5S368S37718462092
- VenterHHenningsenMLBeggSLAntimicrobial resistance in healthcare, agriculture and the environment: the biochemistry behind the headlinesEssays Biochem201761111028258225
- BakALeungDBarrettSEPhysicochemical and formulation developability assessment for therapeutic peptide delivery – a primerAAPS J201517114415525398427
- BiswaroLSda Costa SousaMGRezendeTMBDiasSCFrancoOLAntimicrobial peptides and nanotechnology, recent advances and challengesFront Microbiol2018985529867793
- GottliebCTThomsenLEIngmerHMygindPHKristensenHHGramLAntimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expressionBMC Microbiol20088120519036162
- UmerskaACassisaVBastiatGSynergistic interactions between antimicrobial peptides derived from plectasin and lipid nanocapsules containing monolaurin as a cosurfactant against Staphylococcus aureusInt J Nanomedicine2017125687569928848347
- GarbaczKKamyszWPiechowiczLActivity of antimicrobial peptides, alone or combined with conventional antibiotics, against Staphylococcus aureus isolated from the airways of cystic fibrosis patientsVirulence2017819410027450039
- WuXWangZLiXIn vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction methodAntimicrob Agents Chemother20145895342534924982064
- TheerthagiriRAchuthanandanJMKrishnamurthySAntimicrobial magnetosomes for topical antimicrobial therapyNanobiomaterials in Antimicrobial Therapy: Applications of NanobiomaterialsNorwich (NY)William Andrew Publishing201667101
- SharmaPRozenbaumRTWoudstraWA constant depth film fermenter to grow microbial biofilmsProtoc Exch Epub201738
- CorriganOILiXQuantifying drug release from PLGA nanoparticulatesEur J Pharm Sci2009373–447748519379812
- Mohammadi-SamaniSTaghipourBPLGA micro and nanoparticles in delivery of peptides and proteins; problems and approachesPharm Dev Technol201520438539324483777
- NehmeHSaulnierPRamadanAAAntibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity. Becker K, edPLoS One2018131e018995029298353
- BogeLUmerskaAMatouguiNCubosomes post-loaded with antimicrobial peptides: characterization, bactericidal effect and proteolytic stabilityInt J Pharm20175261–240041228476579
- BrandelliANanostructures as promising tools for delivery of antimicrobial peptidesMini Rev Med Chem201212873174122512554
- AnderssonDIHughesDKubicek-SutherlandJZMechanisms and consequences of bacterial resistance to antimicrobial peptidesDrug Resist Updat201626435727180309
- NizetVAntimicrobial peptide resistance mechanisms of human bacterial pathogensCurr Issues Mol Biol200681112616450883
- Sieprawska-LupaMMydelPKrawczykKDegradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinasesAntimicrob Agents Chemother200448124673467915561843
- BelasRManosJSuvanasuthiRProteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptidesInfect Immun20047295159516715322010
- BraunKPochertALindénMMembrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptidesJ Colloid Interface Sci201647516117027174622
- JainAJainAGulbakeAShilpiSHurkatPJainSKPeptide and protein delivery using new drug delivery systemsCrit Rev Ther Drug Carrier Syst201330429332923662604
- HureauxJLagarceFGagnadouxFToxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in micePharm Res201027342143020054705
- RogerELagarceFBenoitJPThe gastrointestinal stability of lipid nanocapsulesInt J Pharm2009379226026519524655
- GrooACSaulnierPGimelJCFate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral deliveryInt J Nanomedicine201381429124235827
- GrooACBossiereMTrichardLLegrasPBenoitJPLagarceFIn vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumorNanomedicine201510458960125723092
- LiuCKouYZhangXChengHChenXMaoSStrategies and industrial perspectives to improve oral absorption of biological macromoleculesExpert Opin Drug Deliv201815322323329111841